» Authors » Jennifer R Schroeder

Jennifer R Schroeder

Explore the profile of Jennifer R Schroeder including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 798
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dickerson F, Schroeder J, Nimgaonkar V, Gold J, Yolken R
Psychiatry Res . 2020 Jun; 291:113157. PMID: 32593064
Cognitive deficits are characteristic of schizophrenia but their etiology is not understood. Previous studies show an association between viral exposures and cognitive impairment. This meta-analysis was undertaken to determine the...
2.
Hampson A, Schroeder J, Ellefsen K, Yammine L, Epstein D, Preston K, et al.
Clin Pharmacol Ther . 2020 Jun; 108(6):1203-1212. PMID: 32496573
Adherence monitoring is a vital component of clinical efficacy trials, as the regularity of medication consumption affects both efficacy and adverse effect profiles. Pill-counts do not confirm consumption, and invasive...
3.
Panlilio L, Stull S, Kowalczyk W, Phillips K, Schroeder J, Bertz J, et al.
Drug Alcohol Depend . 2019 Jul; 202:200-208. PMID: 31357121
Background: Treatment with opioid agonists is effective for opioid use disorder, but early discontinuation of treatment is a major obstacle to success. Intensive longitudinal methods - which take many repeated...
4.
Stull S, Panlilio L, Moran L, Schroeder J, Bertz J, Epstein D, et al.
Addict Behav . 2019 May; 96:183-191. PMID: 31108264
Background: Individual trajectories of drug use and drug-related problems are highly heterogeneous. There is no standard taxonomy of these trajectories, but one could be developed by defining natural categories based...
5.
Preston K, Schroeder J, Kowalczyk W, Phillips K, Jobes M, Dwyer M, et al.
Drug Alcohol Depend . 2018 Oct; 193:21-28. PMID: 30336389
Background And Aims: Stress can be validly assessed "live" or by a summary evaluation of the very recent past. Using smartphone-based ecological momentary assessment (EMA) combined with end-of-day (EOD) entries,...
6.
Dunn K, Weerts E, Huhn A, Schroeder J, Tompkins D, Bigelow G, et al.
Addict Biol . 2018 Oct; 25(1):e12680. PMID: 30295400
Opioid use disorder (OUD) is a public health crisis. Differences in opioid withdrawal severity that predict treatment outcome could facilitate the process of matching patients to treatments. This is a...
7.
Schroeder J, Phillips K, Epstein D, Jobes M, Furnari M, Kennedy A, et al.
Psychopharmacology (Berl) . 2018 Aug; 235(10):2957-2966. PMID: 30079432
Background: Preliminary evidence suggested that the PPARγ agonist pioglitazone reduces opioid-withdrawal symptoms, possibly by inhibiting increases in proinflammatory cytokines. Methods: A randomized, placebo-controlled clinical trial was conducted utilizing two different...
8.
Florian C, Mansfield S, Schroeder J
Biochem Res Int . 2016 Mar; 2016:2984081. PMID: 26955487
Over 200,000 cases of invasive breast cancer are diagnosed annually; herbicide contaminants in local water sources may contribute to the growth of these cancers. GPR30, a G protein coupled receptor,...
9.
Dunn K, Marcus T, Kim C, Schroeder J, Vandrey R, Umbricht A
Nicotine Tob Res . 2015 Oct; 18(5):1171-9. PMID: 26476459
Introduction: Varenicline (Chantix) is a first-line treatment for smoking cessation but does not produce cessation in many individuals. It may be possible to improve abstinence by co-administering varenicline with other...
10.
Castro-Nallar E, Bendall M, Perez-Losada M, Sabuncyan S, Severance E, Dickerson F, et al.
PeerJ . 2015 Sep; 3:e1140. PMID: 26336637
The role of the human microbiome in schizophrenia remains largely unexplored. The microbiome has been shown to alter brain development and modulate behavior and cognition in animals through gut-brain connections,...